We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Provisional information about the pre and post-operative health status of patients undergoing common elective procedures (hip and knee replacements, varicose vein and groin hernia).
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
As with all products, the MHRA will keep its safety under close review.
Product Safety Report for Pro Light Skin Lightening Beauty Cream presenting a serious chemical risk.
Product Safety Report for Fabrique Par Rodis White Secret Unifying Complexion Serum presenting a serious chemical risk.
Time-series Analysis: PROMs from 2009-10 to 2014-15
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Information about the risks of taking valproate medicines during pregnancy.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).